BIO vs LEE · rev $2.58B vs $201.4M cap
BIO (BIO) versus Lee Enterprises Incorporated (LEE) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Lee Enterprises Incorporated (LEE) is a publishing company listed on NASDAQ.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
LEE does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. LEE currently screens at market cap $201.4M.
Not investment advice. Open the BIO and LEE stock pages for the full models.
Not investment advice.